Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Febrile Neutropenia 5Neoplasms 3Neutropenia 2Fever 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Leukemia 1Hematologic Neoplasms 1

Interventions

Cyclophosphamide 58fludarabine phosphate 53Mycophenolic Acid 36Whole-Body Irradiation 35Peripheral Blood Stem Cell Transplantation 35Busulfan 33Cyclosporine 32Antilymphocyte Serum 27Tacrolimus 26Melphalan 25Filgrastim 22Cord Blood Stem Cell Transplantation 21fludarabine 20Radiotherapy 20Methotrexate 16Methylprednisolone 15Thiotepa 12Etoposide 11Cytarabine 11Granulocyte Colony-Stimulating Factor 7Cyclosporins 7Rituximab 6thymoglobulin 5Sirolimus 5Leucovorin 4Bortezomib 4Bone Marrow Transplantation 4sargramostim 3merphos 3Vorinostat 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma × Ceftazidime × Classical hematology × Clear all
NCT07016165 2025-08-22

Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies

Gadjah Mada University

Phase 4 Recruiting
120 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡